Literature DB >> 28432146

C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes.

Nataschja I Ho1, Marcel G M Camps1, Edwin F E de Haas1, Leendert A Trouw2, J Sjef Verbeek3, Ferry Ossendorp4.   

Abstract

Dendritic cells (DCs) are specialized in Ag engulfment via a wide variety of uptake receptors on their cell surface. In the present study we investigated Ag uptake and presentation of in vivo-formed Ag-Ab complexes by i.v. injecting mice with Ag-specific Abs followed by the cognate Ag. We show by this natural Ab-mediated Ag targeting system that uptake by splenic APC subsets is severely hampered in mice lacking complement factor C1q (C1qa-/-). Moreover, no detectable Ag cross-presentation by CD8α+ DCs from C1qa-/- mice was found. On the contrary, Ag uptake was not hampered by APCs in FcγRI/II/III/IV-deficient (FcγR quadruple-/-) mice, and the cross-presentation ability of CD8α+ DCs was not affected. In conclusion, we show that C1q rather than FcγRs controls the Ab-mediated Ag uptake and its presentation by spleen APC subsets to T cells.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28432146     DOI: 10.4049/jimmunol.1602169

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Regulation of the Cell Biology of Antigen Cross-Presentation.

Authors:  J Magarian Blander
Journal:  Annu Rev Immunol       Date:  2018-02-28       Impact factor: 28.527

Review 2.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

Review 3.  The neonatal Fc receptor in cancer FcRn in cancer.

Authors:  Diana Cadena Castaneda; Guillaume Brachet; Caroline Goupille; Lobna Ouldamer; Valérie Gouilleux-Gruart
Journal:  Cancer Med       Date:  2020-05-05       Impact factor: 4.452

4.  Gene expression analysis of porcine whole blood cells infected with foot-and-mouth disease virus using high-throughput sequencing technology.

Authors:  Jianliang Lv; Yaozhong Ding; Xinsheng Liu; Li Pan; Zhongwang Zhang; Peng Zhou; Yongguang Zhang; Yonghao Hu
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

5.  Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.

Authors:  Nataschja I Ho; Marcel G M Camps; Edwin F E de Haas; Ferry Ossendorp
Journal:  Eur J Immunol       Date:  2018-05-17       Impact factor: 5.532

Review 6.  Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?

Authors:  Nataschja I Ho; Lisa G M Huis In 't Veld; Tonke K Raaijmakers; Gosse J Adema
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

Review 7.  The Complex Association of FcγRIIb With Autoimmune Susceptibility.

Authors:  J Sjef Verbeek; Sachiko Hirose; Hiroyuki Nishimura
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

8.  A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.

Authors:  Andrew G Diamos; Mary D Pardhe; Haiyan Sun; Joseph G L Hunter; Jacquelyn Kilbourne; Qiang Chen; Hugh S Mason
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

Review 9.  Isotype selection for antibody-based cancer therapy.

Authors:  N Vukovic; A van Elsas; J S Verbeek; D M W Zaiss
Journal:  Clin Exp Immunol       Date:  2020-11-30       Impact factor: 5.732

10.  Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity.

Authors:  Andrew G Diamos; Mary D Pardhe; Haiyan Sun; Joseph G L Hunter; Tsafrir Mor; Lydia Meador; Jacquelyn Kilbourne; Qiang Chen; Hugh S Mason
Journal:  Vaccine       Date:  2020-03-12       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.